ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
about
Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases.Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals.Longitudinal study of extended-spectrum-β-lactamase- and AmpC-producing Enterobacteriaceae in household dogs.Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.The microbiome of uncontacted AmerindiansEvaluation of screening methods to detect plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006AmpC beta-lactamases.Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animalsDetection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistance.Antimicrobial resistance, virulence genes and PFGE-profiling of Escherichia coli isolates from South Korean cattle farms.Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting.Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.Chromosomal ampC mutations in cefpodoxime-resistant, ESBL-negative uropathogenic Escherichia coli.
P2860
Q34932937-6FACAA00-45DB-4498-A561-397DFA1A420EQ35140054-6BCF5B95-3FBC-486B-BDA0-EC2887226177Q35579108-BEA1DAB4-0B79-48FA-B374-822B746123C1Q35598386-961310F1-98D2-4F31-940F-5547A4F33F71Q35897279-B69EAE9F-DA79-4B9D-96DF-661BD32C0E2CQ37032817-B5512251-361A-43F9-BD9A-29ABB7C33F53Q37247668-C6A893C6-57E0-4952-962A-7C32382C8619Q37366249-6E2B1006-0137-48FD-8F96-31C4C32A1386Q41766424-3873DDEB-291C-46C3-945B-BE4899C46ECBQ42016476-8119DADE-0CA9-44A0-A1EE-6E63F270C43EQ42089215-B43BAAB8-5855-40BD-8FBE-4428E8E18488Q42203672-C9D6ED19-246B-4A8A-A1C3-118438A9B338Q44352101-79F287E0-1ED4-4EEF-ABC6-6E4E63CEFADAQ46471411-87796CDD-2496-4450-822E-76B1B9ACCCDAQ46738399-81417FB5-E8D8-49A3-A8FF-62F95BF0CD70
P2860
ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
ampC gene expression in promot ...... richia coli clinical isolates.
@en
ampC gene expression in promot ...... richia coli clinical isolates.
@nl
type
label
ampC gene expression in promot ...... richia coli clinical isolates.
@en
ampC gene expression in promot ...... richia coli clinical isolates.
@nl
prefLabel
ampC gene expression in promot ...... richia coli clinical isolates.
@en
ampC gene expression in promot ...... richia coli clinical isolates.
@nl
P2093
P1476
ampC gene expression in promot ...... richia coli clinical isolates.
@en
P2093
Andrew E Simor
David A Boyd
Dobryan M Tracz
Elizabeth Bryce
Marianna Ofner-Agostini
Michael R Mulvey
Romeo Hizon
Shirley Paton
P304
P356
10.1111/J.1574-6968.2007.00672.X
P577
2007-02-26T00:00:00Z